Lumosa Therapeutics Co., Ltd. (TPEX:6535)

Lumosa Therapeutics Revenue

Lumosa Therapeutics had revenue of 5.13M TWD in the quarter ending June 30, 2026, with 135.28% growth. This brings the company's total for the last twelve months to 34.37M, down -7.74% year-over-year. In the year 2025, Lumosa Therapeutics had annual revenue of 35.83M, down -8.49%. That makes Lumosa Therapeutics the 43,533rd largest company in the world by revenue and 2,158th in Taiwan.

• Revenue (ttm): 34.37M
• Revenue Growth: -7.74%
• P/S Ratio: 342.12
• Revenue / Employee: n/a
• Employees: 36
• Market Cap: 11.76B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 22.37M 62.4%
• Asia 13.46M 37.6%

Fiscal year ended Dec 31, 2025 See the full Lumosa Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.83M	-3.32M	-8.49%
Dec 31, 2024	39.15M	-17.76M	-31.21%
Dec 31, 2023	56.92M	30.27M	113.63%
Dec 31, 2022	26.64M	9.28M	53.45%
Dec 31, 2021	17.36M	-4.29M	-19.81%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error